Abstract
Purpose
Increasing potassium intake, especially in populations with low potassium intake and high sodium intake, has emerged as an important population-level intervention to reduce cardiovascular events. Current guideline recommendations, such as those made by the World Health Organisation, recommend a potassium intake of > 3.5 g/day. We sought to determine summary estimates for mean potassium intake and sodium/potassium (Na/K) ratio in different regions of the world.
Methods
We performed a systematic review and meta-analysis. We identified 104 studies, that included 98 nationally representative surveys and 6 multi-national studies. To account for missingness and incomparability of data, a Bayesian hierarchical imputation model was applied to estimating summary estimates of mean dietary potassium intake (primary outcome) and sodium/potassium ratio.
Results
Overall, 104 studies from 52 countries were included (n = 1,640,664). Mean global potassium intake was 2.25 g/day (57 mmol/day) (95% credible interval (CI) 2.05–2.44 g/day), with highest intakes in Eastern and Western Europe (mean intake 3.53g/day, 95% CI 3.05–4.01 g/day and 3.29 g/day, 95% CI 3.13–3.47 g/day, respectively) and lowest intakes in East Asia (mean intake 1.89 g/day; 95% CI 1.55–2.25 g/day). Approximately 31% (95% CI, 30–41%) of global population included have an estimated potassium intake > 2.5 g/day, with 14% (95% CI 11–17%) above 3.5 g/day.
Conclusion
Global mean potassium intake (2.25 g/day) falls below current guideline recommended intake level of > 3.5 g/day, with only 14% (95% CI 11–17%) of the global population achieving guideline-target mean intake. There was considerable regional variation, with lowest mean potassium intake reported in Asia, and highest intake in Eastern and Western Europe.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Increasing potassium intake, particularly in populations with low potassium intake and high sodium intake, has emerged to be an important population-level intervention to reduce cardiovascular events, based on the findings from cohort studies and randomised controlled trials, including the recently reported large cluster randomised controlled trial, the Salt Substitute and Stroke Study (SSaSS) [1, 2]. In the SSaSS trial, a significant reduction in cardiovascular events and mortality was reported by replacing regular salt (100% Sodium Chloride) with a potassium-enriched salt substitute (75% Sodium Chloride and 25% Potassium Chloride), and resulted in a 57% relative increase in potassium intake and an 8.1% relative reduction in sodium intake [2]. Importantly, the SSaSS trial was conducted in rural China, which is reported to have one of the lowest mean intakes of potassium globally (national mean intake 1.7 g/day), along with one of highest mean intakes of sodium (national mean intake 4.8 g/day) [3, 4], and findings from that trial may only apply to some regions of the world.
Current guidelines recommend a potassium intake of more than 3.5 g/day [5], which is based on clinical trials of blood pressure (BP) lowering, and prospective cohort studies relating potassium intake to mortality and cardiovascular events [1, 6, 7]. Higher potassium intake also appears to diminish the magnitude of association between excess sodium intake and cardiovascular events [8], making potassium intake especially important in populations with high mean sodium intakes.
In this systematic review and meta-analysis, we sought to determine global patterns of potassium intake, along with related sodium intake.
Methods
We performed a systematic review and meta-analysis, adhering to the Cochrane Collaboration Guidelines and reported our findings according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Guidelines and the Guidelines for Accurate and Transparent Health Reporting (GATHER) statement [9,10,11]. The meta-analysis was registered with the International Prospective Register of Systematic Reviews (PROSPERO identifier: CRD42022281381). The data that support the findings of this study are available (Supplementary Appendix 2).
Data sources and search strategy
We systematically searched PubMed and Embase databases from database inception to September 2021. The search terms included are detailed in the Supplementary Appendix (eMethods I). Following removal of duplicates, titles and abstracts were screened by two reviewers (CR and RM) using the Rayann web application [12]. The reference lists of included studies and other published meta-analyses were also reviewed. Full texts of remaining articles were independently assessed by two reviewers (CR and RM), with eligibility based on predetermined criteria (see below). Disagreements were resolved by consensus; where a resolution was not reached by discussion, a consensus was reached through a third reviewer (MOD). The systematic search of articles published before September 2021 identified 7236 records. This search was supplemented with a targeted search of governmental websites and global burden of disease database for data deficient countries (i.e. those that did not have studies which included > 1000 participants).
Eligibility criteria
Studies were considered eligible adhered to the following conditions: [1] were representative of a national sample; [2] measured potassium by dietary method (food frequency questionnaire, dietary recall, or food diary) or urinary measurement (24 hour urinary collection, overnight urine, spot or fasting morning urine collection); [3] included greater or equal to 1,000 participants (per country where a sample was collected across multiple countries).
Data extraction
Data were extracted independently by two authors (CR and AC) using a standardized pre-determined data collection form. For each study, we extracted the title, year of publication, country and region the study was performed in, year of measurement, survey sampling method, population type, representativeness (national or sub-national), method of measurement, formula used where applicable (i.e. if daily intake was formula derived based on spot urine sample), daily mean potassium intake (excretion) and standard deviation. Where reported daily mean sodium intake (excretion) and standard deviation were extracted. Regions were recorded as global burden of disease regions and super-regions [13]. Data were compared for inconsistencies and merged into a pre-final dataset which was checked independently by two other reviewers (RM and VG).
Outcomes
The primary outcome was mean potassium intake for all age groups, globally, and by region, country and sex. We also report mean potassium intake among adults only (individuals aged ≥ 18 years old), by region and country. We estimated mean sodium/potassium (Na/K) ratios globally, and by region, country and sex.
Data standardisation and statistical analysis
Potassium and sodium estimates were standardised to grams per day. The measure of variance was extracted as standard deviation; in studies where standard deviation was not reported, where possible it was derived from available information (e.g., Standard Deviation = Standard Error × square root of sample size) following guidance from the Cochrane handbook [9].
We used dietary questionnaire estimates of potassium intake as the reference standard, since urinary potassium excretion represents 75% of potassium intake [14] (compared to ~ 95% for sodium intake for which we used urinary estimates as reference standard). Where sodium estimates were missing (59 observations [29.8%]), values were imputed for these studies as part of the Markov Chain Monte Carlo (MCMC) procedure [15]. An individual study may correspond to multiple observations, for example if a study reported nationally representative estimates for two countries for both men and women, this study would account for four observations. Potassium means were estimated using a three level Bayesian hierarchical model; according to a study within a country, a country within a region and a region. Global potassium and sodium means were estimated by a population weighted average of the estimated region level means. Within a country it is assumed that study level sodium and potassium mean values are linked via a linear model (eMethods 2). We calculated Na/K ratios derived from both millimole and milligram units, respectively (Na/K and Na/K-mg derived), due to lack of consistency of reporting this metric. Model fitting was performed via Hamiltonian Monte Carlo [15] using RStan [16]. Supplementary appendix 3 contains the source code.
Two additional meta-analyses were performed to estimate the proportion of the population achieving a potassium intake of > 2.5 g/day and > 3.5 g/day, respectively. Study level proportions achieving these thresholds were estimated by assuming normal distribution within males and females, respectively, based on the estimated mean and standard deviation of potassium intake. The same correction factor used in the primary model for gender and measurement modality was applied to this model. A three-level Bayesian hierarchical model was fit using RStan [16]. The posterior distributions for estimated proportions exceeding each threshold were recovered using a post Markov chain Monte Carlo simulation procedure.
Results
We identified 193 publications referring to 104 eligible studies; 98 nationally representative surveys and 6 multi-national studies, which corresponded to 198 observations (eFigure 1).
Study characteristics
104 studies were included which represented data from 52 countries (1,640,664 participants). There was representation of at least one country for 17 of 21 global burden of disease regions [13]. No eligible studies were identified for the following regions: Andean Latin America, Central Asia, Central Sub-Saharan Africa and Oceania (eTable 1). 36 studies reported 24-hour urinary potassium excretion (some of which were formula derived) and 68 reported dietary potassium intake, with 3 studies reporting both urinary and dietary potassium measurements (eTable 2).
Global potassium intake
The global mean potassium intake was 2.25 g/day [57.59 mmol] (95% credible interval (CI) 2.05–2.44 g/day). The global mean intake was higher in men (2.40 g/day [61.67 mmol] (95% CI 2.20–2.62 g/day)) than women (2.09 g/day [53.51 mmol] (95% CI 1.91–2.27 g/day)) overall and in all regions (Table 1).
Regional potassium intake
Table 1 reports regional and country-level mean potassium intake. There were regional differences in mean potassium intake, with the lowest mean potassium intake reported in East Asia, 1.89g/day (95% CI 1.55–2.25 mg/day), and the highest mean potassium intake was reported in Eastern Europe at 3.53 g/day (95% CI 3.05–4.01 g/day).
Approximately 35% (95% CI 30–41%) of population of regions included (which excluded 5.5% of the world’s population due to lack of data (eTable 2)) had an estimated potassium intake > 2.5 g/day. 14% (95% CI 11–17%) of population included reported a mean potassium above 3.5 g/day (i.e., an intake meeting WHO recommended intake).
Estimated mean potassium intake among six regions (East Asia, Western Sub-Saharan Africa, South Asia, South-east Asia, Eastern Sub-Saharan Africa, Southern Sub-Saharan Africa) reported mean potassium intake lower than that achieved post intervention in the SaSS trial (i.e. lower than 2.20 g/day) with intakes ranging from 1.89 mg (95% CI 1.55–2.25 g) in East Asia and 2.06 g (95% CI 1.42–2.70 g) in Southern Sub-Saharan Africa (Figs. 1, and 2).
Country-level potassium intake
Among individual countries, the highest potassium intake was reported in Lithuania, with lowest intake reported in Taiwan (Table 1, Fig. 1). Four countries reported mean potassium intake of > 3.5 g; Estonia, Latvia, Russia and Lithuania. eTable 3 reports regional and country level intake in an adult population only which did not materially alter our finding.
Na/K ratio
The global mean mmol Na/K ratio was 2.88 (95% CI 2.56–3.23). The highest regional Na/K ratios were reported in East Asia (3.85; 95% CI 3.04–4.81), Eastern Sub-Saharan Africa (3.42; 95% CI 2.12–5.52) and South Asia (3.39; 95% CI 2.54–4.45) regions. The lowest Na/K ratios were reported in Western Europe (1.68; 95% CI 1.46–1.92) and Eastern Europe (1.82; 95% CI 1.23–2.48) regions (eTable 4, Fig. 3).
Among individual countries, the highest mmol Na/K ratio was reported in China (3.93; 95% CI 3.31–4.64), with the lowest Na/K ratio reported in the Netherlands (1.60; 95% CI, 1.27-1.90) and the United Kingdom (1.60; 95% CI 1.33–1.87) (eTable 4, Fig. 3, eFigure 2). Na/K mg derived ratio are reported in eTable 5 and represented in eFigures 3a and b.
World health organisation targets
No country-level study reported combined intakes of sodium and potassium that achieved World Health Organisation targets, i.e. potassium intake of > 3.5 g/day, while reducing sodium intake to < 2 g/day (Figs. 2 and 4).
Discussion
Our systematic review and meta-analysis reports an estimated global mean daily potassium intake (from available country-level data sources), as well as intake by region, country and gender. The World Health Organisation recommends a target potassium intake of > 3.5 g/day, while reducing sodium intake to < 2 g/day [5, 17], a combined recommendation achieved by none of the countries included in our review. We found that current potassium intake targets are not being achieved at global population level (estimated global potassium intake of 2.25 g/day), regional level (with the possible exception of Eastern Europe) or country level (with the exception of four out of fifty-two included countries). We noted marked regional differences, with lowest potassium intake reported in Asia and Africa, although given limited data availability for the latter there is uncertainty around this estimate. We report that no region achieves the recommended Na/K ratio of 1.0, with the lowest Na/K reported in Western Europe and highest in East Asia [18].
Our study provides a summary meta-analytic estimate of potassium intake globally. Prior studies, including a narrative review by Van Mierlo et al, reported national mean intakes ranging from 1.7 to 3.7 g/day among 21 countries, with lowest intake reported in China [3]. Within individual international studies (e.g. INTERSALT and PURE studies), similar regional variation is reported, with higher potassium excretion in European countries compared to Asia and Africa [19, 20]. We report mean potassium intake within major regions of the world which provides key information on which regions, and countries, might be most suited to the salt substitute employed in the SSaSS trial. However, widespread use of the salt substitute would also need to be guided by knowledge of whether most sodium intake is derived from discretionary or non-discretionary sources, since advocating salt substitutes in communities where most sodium is derived from non-discretionary sources might result in paradoxically increasing sodium intake.
Potassium is an essential mineral and current guideline recommended adequate intakes are based on evidence from blood pressure lowering effects [1], and prospective cohort studies evaluating the association of potassium intake and incidence of cardiovascular events and stroke [21,22,23]. However, the optimal intake range is uncertain, reflected in variations in the adequate intake range between guideline bodies, for example the National Academy of Medicine define adequate intake as 3400 mg for men and 2600 mg for women (which is a reduction from 2005 guideline (4700 mg for both men and women), following a change to methodology of defining adequate intake)), and the European Food and Safety Authority set adequate intake as 3500 mg for both sexes [6, 24]. Sub-optimal potassium intake has led to policy changes in some countries, for example regulations in the United States passed in 2016 mandate displaying potassium content of food on the label.
Although population-level potassium intake has received less attention than sodium intake as a public health strategy to reduce cardiovascular risk, the results of the recent SSaSS trial might suggest that increasing potassium intake may be of greater importance to public health strategies [2, 26]. This study achieved a 57% (803 mg) increase in potassium and 8.1% (350 mg) reduction in sodium resulting in 3.34 mmHg reduction in systolic blood pressure, through salt substitution with 25% KCl, without otherwise modifying dietary quality [2]. A previous cluster randomised trial conducted in Taiwan which randomised clusters to potassium enriched salt also found a significant reduction in cardiovascular mortality in the experimental group, also reporting larger changes in potassium intake than sodium intake [27]. Sodium and potassium intakes are correlated in general populations and their association with cardiovascular events and mortality is interdependent [8]; therefore, strategies to optimise intake should consider both nutrients. Some guidelines make joint recommendations advising < 2g of sodium and > 3.5g of potassium; however, observational studies demonstrate that less than 1% of the population achieve this joint target, and this joint target was not achieved in any country included in our review [6, 8, 28]. The application of the findings of the SSaSS trial is dependent on identifying regions of the world which are potassium deplete (we note that approximately two-thirds of the population have a potassium intake < 2.5 g), with a high sodium intake. Implementation of strategies to increase potassium intake must also be underpinned by an understanding of sources of sodium intake, with countries where discretionary sodium intake is high being appropriate targets for salt supplementation strategies. Previous studies estimate that discretionary sodium intake accounts for more than half of sodium intake in South East Asia; in contrast, it is estimated that the majority of sodium intake in the United States is outside the home, e.g. during food processing with approximately 10% of sodium intake accounted for in the home (i.e., added at the table, or during cooking) [29, 30]. As outlined in the WHO salt reduction strategy, interventions should be tailored to individual countries; discretionary salt intake and cooking practices. Encouraging adherence with dietary guideline recommendations to increase intake of foods items that are rich in potassium (fruit, vegetables and nuts) is an obvious approach to population-level prevention of cardiovascular events. There are challenges to achieving a potassium replete diet such as affordability and food availability. Previous analyses of diets such as the EAT-Lancet diet estimated that the cost exceeded the household per capita income for 1.58 billion people [32]. These observations invite the question of whether potassium supplements, independent of salt substitutes, should be evaluated for cardiovascular prevention in populations.
The Global Burden of Diseases reported mean intakes of sodium in different regions of the world, reporting a global sodium intake above recommended range at 3.95 g/day [4]. Our analytic approach differs from the Global Burden of Disease meta-analytic approach in several ways. First, where there were no data available at country-level we have not reported a country-level estimate, rather a region estimate based on available data. In contrast, prior Global Burden of Disease studies for example the systematic analysis of sodium intakes by Powles et al. [4], impute data for data-deficient countries using information from neighbourring countries. Second, we have applied a correction factor within the model to convert urinary potassium estimates to dietary estimates (which were on average 21% (95% CI 4–30%) higher than urinary potassium estimates), where the Powles et al. study applied an additional pre-processing step to standardise sodium data by cross-walk validation [4]. Given the low number of studies with paired urinary and dietary potassium data, we did not apply this approach. An advantage of our approach, which included the correction factor within the model, is that variability in the estimated conversions were propagated automatically into the variability of the final estimates. Finally, our primary model was a joint model for potassium and sodium, in contrast to Powles et al. meta-analytic estimate of global sodium intake which modelled this electrolyte alone.
Given that sodium and potassium intake are correlated, and interdependent, the proposed use of a sodium/potassium ratio has received attention. However, there are several challenges with use of this metric, including lack of consensus regarding measurement units. For example, use of millimole versus milligram units will provide different ratio values, necessitating work on a standardized approach to reporting. There are difficulties in interpreting the healthiness of an individual diet based on a given ratio, for example diets low in potassium and sodium may render a ‘recommended’ ratio but may be poor in intake of fruits, vegetables and nuts.
Limitations of our study
Our study has several potential limitations. First, despite an extensive search, including a systematic search and targeted search of governmental websites for data-deficient countries, there were limited data available for regions of the world, e.g. Sub-Saharan Africa. Therefore, estimates of global intake must be interpreted with caution given that they are imputed based on the limited data available. Our results highlight data gaps in nutritional assessment including measurement of nutrients such as potassium, particularly in lower income countries. Second, there was variation in the year of measurement with sampling ranging from 1985 to 2020. However, evidence suggests that there has been a reduction in potassium intake over time [33]; therefore, inclusion of surveys from earlier time points are likely to over-estimate current potassium intake. Third, there was variation in method of measurement. All methods of measurement were included to maximise the number of countries represented with a correction factor utilised to standardise variability related to measurement method. However, our results are consistent with findings of studies which used repeated 24-hour urinary measurements. In an individual meta-analysis of six prospective cohort studies which completed repeated 24 hour urinary collections (which included participants from the United States and the Netherlands), Ma et al. also reported potassium intakes below the recommended range, reporting a median potassium excretion of 2535 mg [34]. Fourth, we report estimates overall and among adults only; we do not report estimates by age group. Last, we did not systematically search for studies estimating sodium intake; therefore, sodium estimates should be interpreted with caution. The primary aim of our study was to estimate potassium intake; therefore, our search strategy aimed to identify studies which reported daily potassium intake of a nationally representative sample, where sodium excretion (intake) was reported this data was extracted.
Conclusions
Global mean potassium intake (2.25 g/day) falls below current guideline recommended intake level of > 3.5g/day [17], with only 35% of the global population estimated to achieve this target. There is considerable regional variation, with lowest mean potassium intake reported in Asia, and highest intake in Eastern and Western Europe.
Data availability
All data generated or analysed during this study are included in this published article (and its supplementary information files).
Abbreviations
- SSaSS:
-
Salt substitute and stroke study
- NaCl:
-
Sodium chloride
- KCl:
-
Potassium chloride
- CI:
-
Credible interval
- Na/K:
-
Sodium/potassium
References
Aburto NJ, Hanson S, Gutierrez H et al (2013) Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 346:f1378–f1378. https://doi.org/10.1136/bmj.f1378
Neal B, Wu Y, Feng X et al (2021) Effect of salt substitution on cardiovascular events and death. N Engl J Med. https://doi.org/10.1056/NEJMoa2105675
van Mierlo LAJ (2010) Suboptimal potassium intake and potential impact on population blood pressure. Arch Intern Med 170:1501. https://doi.org/10.1001/archinternmed.2010.284
Powles J, Fahimi S, Micha R et al (2013) Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 3:e003733. https://doi.org/10.1136/bmjopen-2013-003733
World Health Organization (2012) Guideline: potassium intake for adults and children. World Health Organization, Geneva
Committee to Review the Dietary Reference Intakes for Sodium and Potassium, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine (2019) Dietary reference intakes for sodium and potassium. National Academies Press, Washington, DC
Sacks FM, Svetkey LP, Vollmer WM et al (2001) Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344:3–10. https://doi.org/10.1056/NEJM200101043440101
O’Donnell M, Mente A, Rangarajan S et al (2019) Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study. BMJ. https://doi.org/10.1136/bmj.l772
Higgins JPT WV (editors) Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane
Moher D (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264. https://doi.org/10.7326/0003-4819-151-4-200908180-00135
Stevens GA, Alkema L, Black RE et al (2016) Guidelines for accurate and transparent health estimates reporting: the GATHER statement. The Lancet 388:e19–e23. https://doi.org/10.1016/S0140-6736(16)30388-9
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan—a web and mobile app for systematic reviews. Syst Rev 5:210. https://doi.org/10.1186/s13643-016-0384-4
Murray CJ, Ezzati M, Flaxman AD et al (2012) GBD 2010: design, definitions, and metrics. The Lancet 380:2063–2066. https://doi.org/10.1016/S0140-6736(12)61899-6
Holbrook JT, Patterson KY, Bodner JE et al (1984) Sodium and potassium intake and balance in adults consuming self-selected diets. The Am J Clin Nutrit 40:786–793. https://doi.org/10.1093/ajcn/40.4.786
Gelman A, Rubin DB (1996) Markov chain Monte Carlo methods in biostatistics. Stat Methods Med Res 5:339–355. https://doi.org/10.1177/096228029600500402
Stan Development Team (2022) RStan: the R interface to Stan. R package version 2(1):522
World Healt Organisation Guideline (2012) Sodium intake for adults and children. World Health Organization, Geneva
World Health Organization (2002) Diet, nutrition and the prevention of chronic diseases : report of a joint WHO/FAO expert consultation. World Health Organization, Geneva
Intersalt: an international study of electrolyte excretion and blood pressure (1988) Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperat Res Group. BMJ 297:319–328. https://doi.org/10.1136/bmj.297.6644.319
Mente A, O’Donnell MJ, Rangarajan S et al (2014) Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 371:601–611. https://doi.org/10.1056/NEJMoa1311989
Cook NR (2009) Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the trials of hypertension prevention follow-up study. Arch Intern Med 169:32. https://doi.org/10.1001/archinternmed.2008.523
Tunstall-Pedoe H, Woodward M, Tavendale R et al (1997) Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. BMJ 315:722–729. https://doi.org/10.1136/bmj.315.7110.722
O’Donnell MJ, Yusuf S, Mente A et al (2011) Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. https://doi.org/10.1001/jama.2011.1729
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Turck D, Bresson J et al (2016) Dietary reference values for potassium. EFS2. https://doi.org/10.2903/j.efsa.2016.4592
Messerli FH, O’Donnell M, Mente A, Yusuf S (2022) Settling the controversy of salt substitutes and stroke: sodium reduction or potassium increase? Europ Heart J. https://doi.org/10.1093/eurheartj/ehac160
Chang H-Y, Hu Y-W, Yue C-SJ et al (2006) Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. The Am J Clin Nutrit 83:1289–1296. https://doi.org/10.1093/ajcn/83.6.1289
Drewnowski A, Rehm CD, Maillot M et al (2015) The feasibility of meeting the WHO guidelines for sodium and potassium: a cross-national comparison study. BMJ Open 5:e006625–e006625. https://doi.org/10.1136/bmjopen-2014-006625
Batcagan-Abueg APM, Lee JJ, Chan P et al (2013) Salt intakes and salt reduction initiatives in southeast asia: a review. Asia Pacific J Clin Nutrit 22:683–697. https://doi.org/10.6133/apjcn.2013.22.4.04
Harnack LJ, Cogswell ME, Shikany JM et al (2017) Sources of sodium in US adults from 3 geographic regions. Circulation 135:1775–1783. https://doi.org/10.1161/CIRCULATIONAHA.116.024446
Hirvonen K, Bai Y, Headey D, Masters WA (2020) Affordability of the EAT–Lancet reference diet: a global analysis. The Lancet Global Health 8:e59–e66. https://doi.org/10.1016/S2214-109X(19)30447-4
Cogswell ME, Zhang Z, Carriquiry AL et al (2012) Sodium and potassium intakes among US adults: NHANES 2003–2008. The Am J Clin Nutrit 96:647–657. https://doi.org/10.3945/ajcn.112.034413
Ma Y, He FJ, Sun Q et al (2022) 24-hour urinary sodium and potassium excretion and cardiovascular risk. N Engl J Med 386:252–263. https://doi.org/10.1056/NEJMoa2109794
Funding
Open Access funding provided by the IReL Consortium. CR was supported by the Irish Clinical Academic Training (ICAT) Programme, the Wellcome Trust and the Health Research Board (grant number 203930/B/16/Z), the Health Service Executive, National Doctors Training and Planning, and the Health and Social Care, Research and Development Division, Northern Ireland. The funding source had no role in the design and conduct of the study or the publication decision.
Author information
Authors and Affiliations
Contributions
Conceptualization, CR and MO’D; methodology, CR, JF, MO’D; data curation, CR, RM, VG, AC interpretation of data, all authors; formal analysis, CR, JF,AA; writing—original draft preparation, CR,MO’D; writing—review and editing, all authors. Visualization, CR,CJ; supervision, MO’D. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Reddin, C., Ferguson, J., Murphy, R. et al. Global mean potassium intake: a systematic review and Bayesian meta-analysis. Eur J Nutr 62, 2027–2037 (2023). https://doi.org/10.1007/s00394-023-03128-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-023-03128-6